Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices 58409 

but for whom it is not feasible to 

estimate their radiation dose, and on 

whether there is a reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. The Subcommittee on 

Procedures Review was established to 

aid the ABRWH in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstructions. The Subcommittee on 

Procedures Review is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor. 

Matters To Be Discussed: The agenda 

for the Subcommittee meeting includes: 

Review of draft prototype documents for 

informing the public on completed 

Subcommittee procedure reviews; 

discussion of the following ORAU & 

OCAS procedures: PER–012 

(‘‘Evaluation of Highly Insoluble 

Plutonium Compounds’’), PER–009 

(‘‘Target Organs for Lymphoma’’), OCAS 

TIB–0013 (‘‘Special External Dose 

Reconstruction Considerations for 

Mallinckrodt Workers’’), OTIB–014 

(‘‘Rocky Flats Internal Dosimetry CoWorker Extension’’), OTIB–019 

(‘‘Analysis of Co-worker Bioassay Data 

for Internal Dose Assignment’’), OTIB– 

0029 (‘‘Internal Dosimetry Co-worker 

Data for Y–12’’), OTIB–0049 

(‘‘Estimating Doses for Plutonium 

Strongly Retained in the Lung’’), OTIB– 

0047 (External Radiation Monitoring at 

the Y–12 Facility During the 1948–1949 

Period’’), OTIB–0051 (‘‘Effect of 

Threshold Energy and Angular 

Response of NTA Film on Missed 

Neutron Dose at the Oak Ridge Y–12 

Facility’’), OTIB–0052 (‘‘Parameters to 

Consider When Processing Claims for 

Construction Trade Workers’’), OTIB– 

0054 (‘‘Fission and Activation Product 

Assignment for Internal Dose-Related 

Gross Beta and Gross Gamma 

Analyses’’), OTIB–0057 (‘‘External 

Radiation Dose Estimates For 

Individuals Near the 1958 Criticality 

Accident at the Oak Ridge Y–12 Plant’’), 

OTIB–0070 (‘‘Dose Reconstruction 

During Residual Radioactivity Periods at 

Atomic Weapons Employer Facilities’’), 

and TBD 6000 (‘‘Site Profile for Atomic 

Weapons Employers that Worked 

Uranium and Thorium Metals’’); and a 

continuation of the comment-resolution 

process for other dose reconstruction 

procedures under review by the 

Subcommittee. 

The agenda is subject to change as 

priorities dictate. 

This meeting is open to the public, 

but without a public comment period. 

In the event an individual wishes to 

provide comments, written comments 

may be submitted. Any written 

comments received will be provided at 

the meeting and should be submitted to 

the contact person below in advance of 

the meeting. 

Contact Person for More Information: 

Theodore Katz, Designated Federal 

Officer, NIOSH, CDC, 1600 Clifton 

Road, Mailstop E–20, Atlanta, Georgia 

30333, Telephone (513) 533–6800, Toll 

Free 1 (800) CDC–INFO, E-mail 

dcas@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: September 17, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–24006 Filed 9–23–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Scientific Review of P01 

Applications submitted to PAR 08–117. 

Date: October 20, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: Marilyn Moore-Hoon, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute of Dental and 

Craniofacial Research, 6701 Democracy 

Blvd., Rm. 676, Bethesda, MD 20892–4878, 

301–594–4861, mooremar@nidcr.nih.gov. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; RFA DE–11–001 

Collaborative Research on the Transition 

From Acute to Chronic Pain: New Models 

and Measures in Clinical and Preclinical Pain 

Research (R01). 

Date: October 28, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Hotel—Silver Spring, 

8777 Georgia Avenue, 8777 Georgia Avenue, 

Silver Spring, MD 20910. 

Contact Person: Victor Henriquez, PhD, 

Scientific Review Officer, DEA/SRB/NIDCR, 

6701 Democracy Blvd., Room 668, Bethesda, 

MD 20892–4878, 301–451–2405, 

henriquv@nidcr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: September 20, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23951 Filed 9–23–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Review F30s, R03. 

Date: October 18, 2010. 

Time: 2:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Mary Kelly, Scientific 

Review Officer, Scientific Review Branch, 


srobinson on DSKHWCL6B1PROD with NOTICES
58410 Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices 

National Inst of Dental & Craniofacial 

Research, NIH 6701 Democracy Blvd, room 

672, MSC 4878, Bethesda, md 20892–4878, 

301–594–4809, mary_kelly@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: September 16, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23949 Filed 9–23–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Allergy, Immunology, 

and Transplantation Research Committee. 

Date: October 20, 2010. 

Time: 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817. 

Contact Person: Zhuqing Li, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

DHHS/NIH/NIAID, 6700B Rockledge Drive, 

MSC 7616, Bethesda, MD 20892–7616, 301– 

402–9523, zhuqing.li@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: September 20, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23948 Filed 9–23–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of Biotechnology Activities, 

Office of Science Policy, Office of the 

Director; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the meeting of the 

National Science Advisory Board for 

Biosecurity (NSABB). 

Name of Committee: National Science 

Advisory Board for Biosecurity. 

Date: October 19, 2010. 

Time: 8:30 a.m. to 4 p.m. Eastern Daylight 

Time (Times are approximate and subject to 

change). 

Agenda: Presentations and discussions 

regarding: (1) Update of Federal activities 

relevant to the mission of the NSABB; (2) 

activities of NSABB Working Groups on 

Codes of Conduct; Culture of Responsibility; 

International Engagement; Journal Review 

Policies; and Outreach and Education; (3) 

consideration of advances in synthetic 

biology in relation to NSABB 

recommendations regarding biosecurity 

concerns raised by this field; (4) planning for 

future NSABB meetings and activities; and 

(5) other business of the Board. 

Place: National Institutes of Health, 

Building 31, Center Drive, C–Wing, 6th Floor, 

Conference Room 10, Bethesda, Maryland 

20892. 

Contact Person: Ronna Hill, NSABB 

Program Assistant, NIH Office of 

Biotechnology Activities, 6705 Rockledge 

Drive, Suite 750, Bethesda, Maryland 20892, 

(301) 496–9838, hillro@od.nih.gov. 

Under authority 42 U.S.C. 217a, Section 

222 of the Public Health Service Act, as 

amended, the Department of Health and 

Human Services established the NSABB to 

provide advice, guidance and leadership 

regarding federal oversight of dual use 

research, defined as biological research that 

generates information and technologies that 

could be misused to pose a biological threat 

to public health and/or national security. 

The meeting will be open to the public, 

however pre-registration is strongly 

recommended due to space limitations. 

Persons planning to attend should register 

online at: http://oba.od.nih.gov/biosecurity/ 

biosecurity_meetings.html or by calling 

Palladian Partners, Inc. (Contact: Joel 

Yaccarino at 301–650–8660.) Individuals 

who plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should indicate these 

requirements upon registration. 

This meeting will also be webcast. To 

access the webcast, as well as the draft 

meeting agenda and pre-registration 

information, connect to: http:// 

oba.od.nih.gov/biosecurity/ 

biosecurity_meetings.html. Please check this 

site for updates. 

Any member of the public interested in 

presenting oral comments relevant to the 

mission of the NSABB at the meeting may 

notify the Contact Person listed on this notice 

at least 10 days in advance of the meeting. 

Interested individuals and representatives of 

an organization may submit a letter of intent, 

a brief description of the organization 

represented, and a short description of the 

oral presentation. Only one representative of 

an organization may be allowed to present 

oral comments. Both printed and electronic 

copies are requested for the record. In 

addition, any interested person may file 

written comments relevant to the mission of 

the NSABB. All written comments must be 

received by October 12, 2010 and should be 

sent via e-mail to nsabb@od.nih.gov with 

‘‘NSABB Public Comment’’ as the subject line 

or by regular mail to 6705 Rockledge Drive, 

Suite 750, Bethesda, MD 20892, Attention: 

Ronna Hill. The statement should include the 

name, address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

Dated: September 20, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23947 Filed 9–23–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; NIH Joint 

Neuroscience T32 Training Program. 

Date: October 25, 2010. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Anne E. Schaffner, PhD, 

Scientific Review Officer, Division of 

Extramural Research, National Eye Institute, 

National Institutes of Health, 5635 Fishers 

Lane, Suite 1300, MSC 9300, 301–451–2020, 

aes@nei.nih.gov. 


srobinson on DSKHWCL6B1PROD with NOTICES